Acute Kidney Injury

NCT01777165
Study Type: Interventional
Study Design: Allocation: Randomized
End Point Classification:  Safety/Efficacy Study
Intervention Model:  Parallel Assignment
Masking:  Double Blind (Subject, Caregiver, Investigator, Outcomes  Assessor)
Primary Purpose:  Prevention

Official Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Ages Eligible for Study:   ≥18 years of age
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Sponsors and Collaborators: AbbVie

Contact: Sarah Gill, BS, sarah.gill@abbvie.com